Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H25NO3.ClH |
| Molecular Weight | 375.889 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1CCCC(C1)OC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=DKXADVGOZWGRNK-UHFFFAOYSA-N
InChI=1S/C21H25NO3.ClH/c1-2-22-15-9-14-19(16-22)25-20(23)21(24,17-10-5-3-6-11-17)18-12-7-4-8-13-18;/h3-8,10-13,19,24H,2,9,14-16H2,1H3;1H
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14463342 | https://www.ncbi.nlm.nih.gov/pubmed/13616780
Curator's Comment: The most characteristic psychological
aspects of the JB 318 (N-ethyl-3-piperidyl-benzilate) reaction were self-preoccupation, self-imposed stereotypy of behavior, and a reduced awareness of the environment. The post-JB 318 hypomania was a sort
of emotional rebound phenomenon—a defensive reaction akin to counterphobic
mechanisms which consisted of denial and reaction formation.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1907609 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11087580 |
1.46 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13192610 |
Primary | Unknown Approved UseUnknown |
||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain. | 2001-06-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14463342
N-Ethyl-3-piperidyl benzilate (JB-318) 15 mg were administered orally to 10 medical students
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13791503
Curator's Comment: JB-318* is a JB-318 tritiated derivative.
In order to determine whether perehlorie acid completely extracted
JB-318* from tissues, various amounts (1--10 ug) of JB-318* were added to aqueous homogenates of brain and kidney which were then incubated
at 0 degrees for 1 hour.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2Y9D6CFP9H
Created by
admin on Tue Apr 01 16:28:49 GMT 2025 , Edited by admin on Tue Apr 01 16:28:49 GMT 2025
|
PRIMARY | |||
|
DTXSID801344635
Created by
admin on Tue Apr 01 16:28:49 GMT 2025 , Edited by admin on Tue Apr 01 16:28:49 GMT 2025
|
PRIMARY | |||
|
5957-24-4
Created by
admin on Tue Apr 01 16:28:49 GMT 2025 , Edited by admin on Tue Apr 01 16:28:49 GMT 2025
|
PRIMARY | |||
|
10090905
Created by
admin on Tue Apr 01 16:28:49 GMT 2025 , Edited by admin on Tue Apr 01 16:28:49 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD